| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |